Abstract
Background: Platelets contain a high amount of potentially active A subunit dimer of coagulation factor XIII (cellular FXIII; cFXIII). It is of cytoplasmic localization, not secreted, but becomes translocated to the surface of platelets activated by convulxin and thrombin (CVX+Thr).
Objective: To explore the difference in cFXIII translocation between receptor mediated and non-receptor mediated platelet activation and if translocation can also be detected on platelet-derived microparticles. Our aim was also to shed some light on the mechanism of cFXIII translocation.
Methods: Gel-filtered platelets were activated by CVX+Thr or Ca2+-ionophore (calcimycin). The translocation of cFXIII and phosphatidylserine (PS) to the surface of activated platelets and platelet-derived microparticles was investigated by flow cytometry, immunofluorescence and immune electron microscopy. Fluo-4-AM fluorescence was used for the measurement of intracellular Ca2+ concentration.
Results: Receptor mediated activation by CVX+Thr exposed cFXIII to the surface of over 60% of platelets. Electron microscopy revealed microparticles with preserved membrane structure and microparticles devoid of labeling for membrane glycoprotein CD41a. cFXIII was observed on both types of microparticles but was more abundant in the absence of CD41a. Rhosin, a RhoA inhibitor significantly decreased cFXIII translocation. Non-receptor mediated activation of platelets by calcimycin elevated intracellular Ca2+ concentration, induced the translocation of PS to the surface of platelets and microparticles, but failed to expose cFXIII.
Conclusions: The elevation of intracellular Ca2+ concentration is sufficient for the translocation of PS from the internal layer of the membrane, while the translocation of cFXIII from the platelet cytoplasm requires additional receptor mediated mechanism(s).
Objective: To explore the difference in cFXIII translocation between receptor mediated and non-receptor mediated platelet activation and if translocation can also be detected on platelet-derived microparticles. Our aim was also to shed some light on the mechanism of cFXIII translocation.
Methods: Gel-filtered platelets were activated by CVX+Thr or Ca2+-ionophore (calcimycin). The translocation of cFXIII and phosphatidylserine (PS) to the surface of activated platelets and platelet-derived microparticles was investigated by flow cytometry, immunofluorescence and immune electron microscopy. Fluo-4-AM fluorescence was used for the measurement of intracellular Ca2+ concentration.
Results: Receptor mediated activation by CVX+Thr exposed cFXIII to the surface of over 60% of platelets. Electron microscopy revealed microparticles with preserved membrane structure and microparticles devoid of labeling for membrane glycoprotein CD41a. cFXIII was observed on both types of microparticles but was more abundant in the absence of CD41a. Rhosin, a RhoA inhibitor significantly decreased cFXIII translocation. Non-receptor mediated activation of platelets by calcimycin elevated intracellular Ca2+ concentration, induced the translocation of PS to the surface of platelets and microparticles, but failed to expose cFXIII.
Conclusions: The elevation of intracellular Ca2+ concentration is sufficient for the translocation of PS from the internal layer of the membrane, while the translocation of cFXIII from the platelet cytoplasm requires additional receptor mediated mechanism(s).
Original language | English |
---|---|
Pages (from-to) | 1223–1235 |
Number of pages | 13 |
Journal | Journal of Thrombosis and Haemostasis |
Volume | 20 |
Issue number | 5 |
Early online date | 21 Feb 2022 |
DOIs | |
Publication status | Published - 20 Apr 2022 |
Bibliographical note
ACKNOWLEDGEMENTSThe authors are indebted to Prof. Edit Buzás MD, PhD (Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary) for the expert discussion on extracellular vesicles. We also thank Ms. Ágnes Bana (Faculty of Medicine, University of Debrecen, Debrecen, Hungary) for the expert assistance in immunofluorescence studies and to Ms. Fanni Puter (Faculty of Medicine, University of Debrecen, Debrecen, Hungary) for her technical help.
The research was funded by a grant from the National Research, Development and Innovation Office (NKFIH) (K129287), by the GINOP 2.3.2-15-2016-00050 project co-financed by the European Union and the European Regional Development Fund and by the Hungarian Academy of Science (11014 project). M.C. is a Marie Skłodowska-Curie Innovative Training Network (ITN) fellow (grant Agreement number: 813834 - pHioniC - H2020-MSCA-ITN-2018).
N.J.M was funded by the British Heart Foundation PG/15/82/31721, Friends of Anchor and the Aberdeen Development Trust.
Data Availability Statement
SUPPORTING INFORMATIONAdditional supporting information may be found in the online version of the article at the publisher’s website.
Keywords
- cell-derived microparticles
- factor XIII
- flow cytometry
- immune electron microscopy
- platelet activation